期刊文献+

碳酸镧对骨化三醇冲击治疗慢性肾衰竭持续非卧床腹膜透析继发性甲状旁腺功能亢进患者血钙、血磷影响的研究 被引量:10

Ef ects of Lanthanum Carbonate on Serum Calcium and Phosphorus of CAPD Patients with Chronic Renal Failure Receiving Calcitriol Pulse h erapy Due to Secondary Hyperparathyroidism
原文传递
导出
摘要 目的探讨碳酸制在慢性肾衰竭持续非卧床腹膜透析(CAPD)患者应用骨化三醇治疗继发性甲状旁腺功能亢进(SHPT)时对血钙和血磷的影响。方法将2013年3~6月青岛市市立医院东院腹膜透析中心的CAPD导致SHPT的患者随机分为两组。碳酸镧组予以口服碳酸镧和骨化三醇冲击治疗,碳酸钙组给予碳酸钙和骨化三醇治疗,观察患者血清钙、磷、iPTH的变化。统计分析采用SPSS17.0软件。结果共纳入40例患者,两组各20例。治疗12周后,碳酸镧组患者血磷(t=5.095,P=0.000)和iPTH(t=1.225,P=0.000)水平均明显下降,且碳酸镧组血钙(t=1.127,P=0.001)、血磷(t=2.035,P=0.000)水平明显低于碳酸钙组。结论碳酸镧能有效治疗CAPD患者应用骨化三醇冲击治疗SHPT时的高钙血症和高磷血症。 Objective To explore and discuss the effects of lanthanum carbonate on serum calcium and phosphorus of continuous ambulatory peritoneal dialysis (CAPD) patients with chronic renal failure receiving calcitriol pulse therapy due to secondary hyperparathyroidism (SHPT). Methods CAPD patients caused by SHPT in peritoneal dialysis centre of the Qingdao Municipal Hospital of Eastern Hospital from March to June, 2013 were selected and randomly divided into two groups (lanthanum carbonate group and calcium carbonate group). The lanthanum carbonate group were treated with oral lanthanum carbonate and calcitriol pulse therapy, while the calcium carbonate group were treated with calcium carbonate and calcitriol. Change of levels of serum calcium, phosphorus and iPTH were observed and statistic analysis was conducted using SPSS 17.0. Results A total of 40 CAPD week treatment, levels of serium phosphate (t=5.095, P=0.000) patients were included, 20 cases in each group. After 12- and iPTH (t=1.225, P=0.000) in the lanthanum carbonate group were significantly lower than those before treatment. The levels of serum calcium (t= 1.127, P=0.001) and phosphate (t=2.035, P=0.000) in the lanthanum carbonate group were significantly lower than those in the calcium carbonate group (P〈0.05). Conclusion Lanthanum carbonate serves as a useful approach to improve hypercalcemia and the hyperphosphatemia in CAPD patients receiving calcitriol pulse therapy due to SHPT.
出处 《中国循证医学杂志》 CSCD 2014年第6期651-654,共4页 Chinese Journal of Evidence-based Medicine
关键词 碳酸镧 骨化三醇 持续非卧床腹膜透析 继发性甲状旁腺功能亢进 Lanthanum carbonate Calcitriol Continuous ambulatory peritoneal dialysis Secondary hyperparathyroidism
  • 相关文献

参考文献18

  • 1Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 2006, 69(11): 1945-1953.
  • 2陈玉琼,王美云.血液灌流联合血液透析治疗尿毒症顽固性皮肤瘙痒[J].江苏大学学报(医学版),2007,17(4):338-339. 被引量:16
  • 3<活性维生素D的合理应用>专家协作组.活性维生素D在慢性肾脏病继发性甲旁亢中合理应用的专家共识(修订版)[J].中华肾脏病杂志,2005,21(11):698-699. 被引量:97
  • 4Malberti F. Management of hyperphosphatemia in dialysis patients: the role of phosphate binders. G Ital Nefrol, 2010, 27(Suppl 52): 47-54.
  • 5Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol, 2004, 15(12): 2959-2964.
  • 6Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int, 2007, 71(1): 31-38.
  • 7Martinez I, Saracho R, Montenegro J, et al. The importance of dietary calcium and phosphorus in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis, 1997, 29(3): 496-502.
  • 8孙志宏,安惠霞,杨霞.慢性肾衰血透患者甲状旁腺激素与营养的关系研究[J].哈尔滨医科大学学报,2008,42(5):484-487. 被引量:11
  • 9Feldman D, Sampson JN, Rudser KD,et al. Treatment of secondary hyperparathyroidism in patients with chronic renal failure maintained on hemodialysis (CKD stage 5). Endocrinologia J, 1986, 32(6): 863-874.
  • 10Ishida M, Yao N, Yachiku S, et al. Management of calcium, phosphorus and bone metalbolian in dialysis patients using sevelamer hydrochloride and vitamin D therapy. Ther Apher Dial, 2005, 9(Suppl 1): 16-21.

二级参考文献13

  • 1马祖等,郑智华,叶任高,张涤华,吴培根,沈清瑞,余学清.血液透析患者营养状况的评估方法研究[J].新医学,2004,35(10):600-601. 被引量:26
  • 2Berqstrom J, Lindholm B. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare[ J] ?. Kidney lnt Suppl, 1993, 40 : S39-50.
  • 3Valenzuela RG, Giffoni AG, Cuppari L, et al. Nutritional condition in chronic renal failure patients treated by hemodialysis in Amazonas [ J ]. Rev Assoc Med Bras,2003,49 ( 1 ) :72-78.
  • 4Smoqorzewski M, Piskorska G, Borum PR, et al. Chronic renal failure, parathytroid hormone and fatty acids oxidation in skeletal muscle [ J ]. Kidney Int, 1988,33 (2) :555-560.
  • 5Rezende LT, Cuppari L, Carvalho AB, et al. Nutritional status of hemodialysis patients with secondary hyperparathyroidism [ J ]. Brazi J Medl Biol Res,2000,33 ( 11 ) : 1305 -1311.
  • 6Yasunaga C, Matsuo K, Yanagida T,et al. Early effects of parathyroidectomy on erythropoietin production in secondary hyperparathyroidism[ J ]. Am J Surg,2002,183 (2) : 199-204.
  • 7Goicoechea M,Pde sequera,Ochando A,et al.Uremic pruritus:an unresolved problem in hemodialysis patients[J].Nephon,1999,82(1):73-74.
  • 8王质刚.血液净化学[M].2版.北京:北京科学技术出版社,2005:346-350.
  • 9Szepietowski JC,Sikora M,Kusztal M,et al.Uremic pruritus:a clinical study of maintenance hemodialysis patients[J].J Dermatol,2002,29 (10):621-627.
  • 10London GM,Marty C,Marchais SJ,et al.Arterial calcifications and bonehistomorphometry in end-stage renal disease[J].J Am Soc Nephrol,2004,15(6)1939-1943.

共引文献120

同被引文献103

引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部